Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease

Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease

Aim. To compare the effectiveness and safety of direct oral anticoagulants (DOACs) with a vitamin K antagonist (VKA) in patients with atrial fibrillation (AF) and stage 4 and 5 chronic kidney disease (CKD).Material and methods. We searched in the PubMed, Google Scholar, and Web of Science databases...

Full description

Saved in:
Bibliographic Details
Main Authors: E. G. Skorodumova, O. A. Rubanenko, A. O. Rubanenko, S. T. Enginoev, M. A. Kercheva, E. L. Zaslavskaya, E. V. Efremova, E. Yu. Gubareva, I. N. Lyapina, R. M. Velieva, E. A. Skorodumova, A. V. Siverina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2024-04-01
Series:Российский кардиологический журнал
Subjects:
vitamin k antagonist
direct oral anticoagulants
end-stage renal failure
atrial fibrillation
chronic kidney disease
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5577
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://russjcardiol.elpub.ru/jour/article/view/5577

Similar Items